Keystone Financial Group (Kentucky)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Keystone Financial Group (Kentucky)'s BMY Position: Q2 2026 in Review
Keystone Financial Group (Kentucky) increased its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2026, buying an estimated $60.2K and bringing the position to 8,578 shares worth $494K. The position accounts for 0.03% of the portfolio, ranked #329.
Keystone Financial Group (Kentucky) first reported a position in BMY in Q4 2019 and has held it in 15 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Keystone Financial Group (Kentucky) held 8,578 shares of Bristol-Myers Squibb worth $494K as of Q2 2026.
- Keystone Financial Group (Kentucky) bought 1,048 Bristol-Myers Squibb shares in Q2 2026, an estimated $60.2K.
- Bristol-Myers Squibb made up 0.03% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #329 holding.
- Keystone Financial Group (Kentucky) first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 15 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.